The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+ Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy

BACKGROUND: Trastuzumab improves survival outcomes in patients with HER2+ metastatic breast cancer. The Long-Her study was designed to identify clinical and molecular markers that could differentiate long-term survivors from patients having early progression after trastuzumab treatment. METHODS: Dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gámez-Pozo, Angelo, Pérez Carrión, Ramón M., Manso, Luis, Crespo, Carmen, Mendiola, Cesar, López-Vacas, Rocío, Berges-Soria, Julia, López, Isabel Álvarez, Margeli, Mireia, Calero, Juan L. Bayo, Farre, Xavier González, Santaballa, Ana, Ciruelos, Eva M., Afonso, Ruth, Lao, Juan, Catalán, Gustavo, Gallego, José V. Álvarez, López, José Miramón, Bofill, Francisco J. Salvador, Borrego, Manuel Ruiz, Espinosa, Enrique, Vara, Juan A. Fresno, Zamora, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203741/
https://www.ncbi.nlm.nih.gov/pubmed/25330188
http://dx.doi.org/10.1371/journal.pone.0109611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203741/
https://www.ncbi.nlm.nih.gov/pubmed/25330188
http://dx.doi.org/10.1371/journal.pone.0109611

Ejemplares similares